Your browser doesn't support javascript.
loading
Pathophysiology of the right ventricle and its pulmonary vascular interaction.
Hemnes, Anna R; Celermajer, David S; D'Alto, Michele; Haddad, Francois; Hassoun, Paul M; Prins, Kurt W; Naeije, Robert; Vonk Noordegraaf, Anton.
Afiliación
  • Hemnes AR; Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, USA anna.r.hemnes@vumc.org.
  • Celermajer DS; Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • D'Alto M; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Haddad F; Department of Cardiology, Monaldi Hospital, Naples, Italy.
  • Hassoun PM; Division of Cardiovascular Medicine, Stanford University and Stanford Cardiovascular Institute, Palo Alto, CA, USA.
  • Prins KW; Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Naeije R; Lillehei Heart Institute, Cardiovascular Division, University of Minnesota Medical School, Minneapolis, MN, USA.
  • Vonk Noordegraaf A; Université Libre de Bruxelles, Brussels, Belgium.
Eur Respir J ; 2024 Aug 29.
Article en En | MEDLINE | ID: mdl-39209482
ABSTRACT
The right ventricle and its stress response is perhaps the most important arbiter of survival in patients with pulmonary hypertension of many causes. The physiology of the cardiopulmonary unit and definition of right heart failure proposed in the 2018 World Symposium on Pulmonary Hypertension have proven useful constructs in subsequent years. Here, we review updated knowledge of basic mechanisms that drive right ventricular function in health and disease, and which may be useful for therapeutic intervention in the future. We further contextualise new knowledge on assessment of right ventricular function with a focus on metrics readily available to clinicians and updated understanding of the roles of the right atrium and tricuspid regurgitation. Typical right ventricular phenotypes in relevant forms of pulmonary vascular disease are reviewed and recent studies of pharmacological interventions on chronic right ventricular failure are discussed. Finally, unanswered questions and future directions are proposed.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur Respir J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur Respir J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...